Dario Alessi, of the Medical Research Council Protein Phosphorylation Unit, has rounded off an extraordinary year by winning the sixth high profile award of his career and the fourth this year.

Dario secured a highly prestigious Philip Lev …more

Philip Cohen has been awarded the Bristol-Myers Squibb Foundation Distinguished Achievement Award in Metabolic Research for his work on diabetes.

The award recognises his leading role in identifying how insulin accelerates the conversion o …more

A paper published by Philip Cohen and his colleagues in the October 2000 issue of the Biochemical Journal (Davies et al, (2000) Biochem, J., 307, 95-105) is featured as a 'Hot Paper' in the 2 September 2002 issue of The Scientist magazine (Volume 16, …more

It was a beautiful night on 12 August 2002, when six fearless volunteers swam from Tayport Harbour to Broughty Ferry, to raise funds for Diabetes UK

The swimming team all have a connection with diabetes: Irene Blair has diabetes, Liz Downe …more

The Hike Itself:

• 24th November to 3rd December 2001.

• Participants: 68 from around Scotland plus 2 from Maggie's Centre.

• Distance covered: 140 km over 5 full days & 2 half days (around 20 km/day …more

Sir Philip Cohen ranked second of the 561,800 biologists and biochemists who published research papers over the ten years between 1992 and 2002. During this period, his research papers were cited 14,186 times, according to the Philadelphia based Inst …more

Graham Rena, a postdoc in Philip Cohen's Group, won the prize for the best talk by a Younger Scientist at a meeting on Insulin held at Grassmere in the Lake District in North West England from May 22nd-24th 2002. The meeting, organised by the Rank Pr …more

The MRC PPU have announced the renewal of their major collaboration with the pharmaceutical industry.

Agreement has been reached with six of the world's major pharmaceutical companies (AstraZeneca, Boehringer Ingelheim International GmbH,  …more

Sheelagh Frame, a Postdoctoral Researcher who worked in both the DSTT and the MRC Unit, left the Unit on the 29th March 2002 after spending 3 years here. Sheelagh has decided to re-enter the biotechnology sector (having worked in Onyx Pharmaceuticals …more

A brand-new laboratory complex has just been opened next to the Division of Signal Transduction Therapy (DSTT) on the first floor of the MSI-WTB Complex. The laboratory houses the research group of Professor Tricia Cohen and is shared with that of Dr …more